Increased risk of hepatocellular carcinoma in viral hepatitis associated end-stage liver disease (ESLD).

被引：0
|
作者：
Perez, RG [1 ]
Zein, NN [1 ]
Steers, JL [1 ]
Wiesner, RH [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT GASTROENTEROL & LIVER TRANSPLANTAT,ROCHESTER,MN 55905
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Alcohol consumption and not metabolic abnormalities is associated with increased hepatocellular carcinoma risk in patients with End-Stage Liver Disease
    Tamimi, Tarek I. Abu-Rajab
    Hanouneh, Ibrahim A.
    Hazin, Ribhi
    Lopez, Rocio
    Zein, Nizar N.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A824 - A824
  • [2] Clinical manifestations of end-stage liver disease (ESLD) in patients with chronic viral hepatitis and advanced liver fibrosis assessed by elastography
    Morente, A
    Romero, M
    Barreiro, P
    Rivas, P
    Maida, I
    Moreno, A
    Muñoz, F
    Gonzalez-Lahoz, J
    García-Samaniego, J
    Soriano, V
    [J]. HEPATOLOGY, 2005, 42 (04) : 338A - 339A
  • [3] Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis
    Hyung Woo Kim
    Young Su Joo
    Shin Chan Kang
    Hee Byung Koh
    Seung Hyeok Han
    Tae-Hyun Yoo
    Shin-Wook Kang
    Jung Tak Park
    [J]. Scientific Reports, 12
  • [4] Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis
    Kim, Hyung Woo
    Joo, Young Su
    Kang, Shin Chan
    Koh, Hee Byung
    Han, Seung Hyeok
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Park, Jung Tak
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Efficacy of hepatitis A vaccine in patients with end-stage liver disease (ESLD) and after liver transplantation (LT).
    Dumot, JA
    Barnes, DS
    Younossi, Z
    Henderson, JM
    Carey, WD
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1259 - A1259
  • [6] Mayo end-stage liver disease (MELD) score: Causes of variability in patients with end-stage liver disease (ESLD)
    Yousfi, MM
    Douglas, DD
    Malinchoc, M
    Mulligan, DC
    Rakela, J
    Moss, AA
    Harrison, ME
    Balan, V
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A371 - A371
  • [7] Liver transplantation for end-stage liver disease related to viral hepatitis
    Tisone, G
    Angelico, M
    Vennarecci, G
    Palmieri, G
    Orlando, G
    Iaria, G
    Baiocchi, L
    Casciani, CU
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1843 - 1845
  • [8] Risk of End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort
    Bruden, Dana J. T.
    McMahon, Brian J.
    Townshend-Bulson, Lisa
    Gounder, Prabhu
    Gove, Jim
    Plotnik, Julia
    Homan, Chriss
    Hewitt, Annette
    Barbour, Youssef
    Spradling, Philip R.
    Simons, Brenna C.
    McArdle, Susan
    Bruce, Michael
    [J]. HEPATOLOGY, 2017, 66 (01) : 37 - 45
  • [9] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
    Levi, David M.
    Tzakis, Andreas G.
    Martin, Paul
    Nishida, Seigo
    Island, Eddie
    Moon, Jang
    Selvaggi, Gennaro
    Tekin, Akin
    Madrazo, Beatrice L.
    Narayanan, Govindarajan
    Garcia, Monica T.
    Feun, Lynn G.
    Tryphonopoulos, Panagiotis
    Skartsis, Nikolaos
    Livingstone, Alan S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 727 - 734
  • [10] Stem cell therapy for hepatocellular carcinoma and end-stage liver disease
    Abdellateif, Mona S.
    Zekri, Abdel-Rahman N.
    [J]. JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
12345